Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference17 articles.
1. Management of type 2 diabetes: new and future developments in treatment;Tahrani;Lancet,2011
2. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins;Wood;Br J Nutr,2003
3. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose;Kanai;J Clin Invest,1994
4. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial;Ferrannini;Diabetes Care,2010
5. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial;Bailey;Lancet,2010
Cited by 528 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on serum uric acid levels in patients with chronic kidney disease: a systematic review and network meta-analysis;BMJ Open Diabetes Research & Care;2024-01
2. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD;Journal of the American Society of Nephrology;2023-12-12
3. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease;Journal of Diabetes Research;2023-12-06
4. Synthesis, crystal structure, spectral analysis, DFT calculations, docking studies, in vitro biological activity evaluation and in silico drug-likeness prediction of a novel L-xylose derivative;Journal of Molecular Structure;2023-12
5. Inibitori del cotrasportatore sodio-glucosio di tipo 2 in pazienti sottoposti a trapianto renale;Giornale di Clinica Nefrologica e Dialisi;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3